Description
SPECIAL PROTEINS ANALYZER COST PER TEST - DEOB OY2 FUNDS
Base award description: SPECIAL PROTEINS ANALYZER COST PER TEST
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-10-01+$185,920= $185,920
- Mod P000012024-12-30-$60,019= $125,901
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-10-01 | +$185,920 | $185,920 | SPECIAL PROTEINS ANALYZER COST PER TEST |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-12-30 | −$60,019 | $125,901 | SPECIAL PROTEINS ANALYZER COST PER TEST - DEOB OY2 FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ETZEQNG96NN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0395 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $69,423 | FY2026 |
| 36C24826N0254 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $74,121 | FY2026 |
| 36C25026F0294 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $183,301 | FY2026 |
| 36C24126N0140 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $276,000 | FY2026 |
| 36C24126A0010 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C26226N0172 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $428,607 | FY2026 |
Other recipients under 6515 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826P1275 | ENCORE MEDICAL, L.P. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $9,800 | FY2026 |
| 36C24826N0893 | GLOMAX, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $309,731 | FY2026 |
| 36C24826N0898 | ENCORE MEDICAL, L.P. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $13,348 | FY2026 |
| 36C24826N0895 | PERMOBIL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $18,598 | FY2026 |
| 36C24826N0860 | DISORB SYSTEMS INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $49,238 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24824N0055_3600_36C24822D0004_3600 · retrieved 2026-09-26.